Pharmacokinetic Study of DA-020
In the register
The register attaches this trial to DA-001 / DA-002 / DA-005 (Applied Biology), currently at “Phase 1/2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Early phase 1
- Sponsor
- Applied Biology, Inc.
- Participants (registry)
- 60
- Start
- April 2026 (planned)
- Primary completion
- October 2026 (planned)
- Study completion
- November 2026 (planned)
- Last registry update
- April 2026
- Countries
- Brazil, Italy
Conditions studied: Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Interventions: DA-020 (0.1%), DA-020 (0.2%), DA-020 (0.5%)
Other trials of DA-001 / DA-002 / DA-005
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Pharmacokinetic Study of Topical Phenylephrine
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.